Dermatophagoides farinae-specific IgG responses in atopic dogs undergoing allergen-specific immunotherapy with aqueous vaccines.
The molecular and immunologic mechanisms associated with successful allergen-specific immunotherapy (ASIT) have not been completely elucidated. The aim of this study was to characterize the changes in Dermatophagoides farinae-specific IgG in atopic dogs undergoing ASIT using aqueous vaccines. Fifteen atopic dogs with a positive skin test reaction to D. farinae were treated with aqueous vaccines for a minimum of 2 months following a standard protocol. Serum samples were collected before and during therapy and used to probe Western blots containing separated proteins of D. farinae. IgG responses were detected using a polyclonal goat anticanine IgG antibody and a chromogenic substrate 3,3'-diaminobenzidine. The blots were analysed using a semiquantitative digital image analysis system that evaluated the number and molecular weight of bands, as well as their intensity, which was related to IgG concentration. Prior to ASIT, all dogs showed allergen-specific IgG responses to various antigens of D. farinae. During ASIT, there was a significant increase in the total quantity of D. farinae-specific IgG antibodies to various antigens from the mite (P = 0.015). Significant increases were observed for a 98-kDa band (P = 0.015), likely to be Der f 15; bands with molecular weights between 50 and 70kDa (P=0.012); and bands between 30 and 45 kDa (P = 0.035). These findings provide support for the hypothesis that ASIT induces IgG blocking antibodies to allergens known to be relevant in canine atopic dermatitis.
Hou
Chia-Chun
CC
The Royal Dick School of Veterinary Studies, University of Edinburgh, Edinburgh, UK.
Griffin
Craig E
CE
Hill
Peter B
PB
D000818:Animals; D039741:Antigens, Dermatophagoides / Q000276:immunology*; D003876:Dermatitis, Atopic / Q000276:immunology / Q000662:veterinary*; D004283:Dog Diseases / Q000276:immunology*; D004285:Dogs; D007074:Immunoglobulin G / Q000378:metabolism*; D016233:Immunotherapy, Active / Q000662:veterinary*; D014612:Vaccines / Q000276:immunology
D039741:Antigens, Dermatophagoides; D007074:Immunoglobulin G; D014612:Vaccines